Peter Jackuliak, Juraj Payer
Osteoporosis is now recognized, along with cardiovascular and oncologic diseases for a civilization disease. It is a globally
significant growing health problem due to the high incidence of fractures contributes significantly to morbidity,
mortality and increased healthcare costs. Its growth is exponential and is related, as with other lifestyle-related diseases,
with increases in life expectancy of the population and lifestyle changes. There is a wealth of data confirming the
high incidence of osteoporosis in patients with diabetes mellitus type 1 and also type 2.
In Type 1 diabetes is reduced bone density and therefore the diagnosis of osteoporosis can be performed on the basis
of a densitometric examination. Patients with type 2 diabetes can have the bone density in normal range and therefore
a large proportion of high-risk patients will be not optimal managed. For Type 2 Diebetes is recommended to use
a combination of BMD exam and Trabecular Bone Score (TBS), which can assesses the bone quality. The optimal management
of osteoporosis in diabetes includes adequate supplementation of vitamin D and calcium. Of course, as with
all other diabetic complications, it is necessary to achieve an optimal metabolic compensation. However, when choosing
antidiabetic therapy, it is also necessary to think about the effect of individual preparates on bone metabolism.
The review article aims to emphasize the need for the comprehensive care of diabetics to omit the risk of osteoporosis.